Preliminary results show improvement in MS symptoms

(NIH/National Institute of Neurological Disorders and Stroke) Combining the estrogen hormone estriol with Copaxone, a drug indicated for the treatment of patients with relapsing forms of multiple sclerosis, may improve symptoms in patients with the disorder, according to preliminary results from a clinical study of 158 patients with relapsing remitting multiple sclerosis. The findings were presented today by Rhonda Voskuhl, M.D., from the University of California, Los Angeles, at the American Academy of Neurology Annual Meeting in Philadelphia.
Source: EurekAlert! - Biology - Category: Biology Source Type: news